115 related articles for article (PubMed ID: 16166301)
1. Essential role for Ras signaling in glioblastoma maintenance.
Holmen SL; Williams BO
Cancer Res; 2005 Sep; 65(18):8250-5. PubMed ID: 16166301
[TBL] [Abstract][Full Text] [Related]
2. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
3. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
Holland EC; Celestino J; Dai C; Schaefer L; Sawaya RE; Fuller GN
Nat Genet; 2000 May; 25(1):55-7. PubMed ID: 10802656
[TBL] [Abstract][Full Text] [Related]
4. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
5. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
[TBL] [Abstract][Full Text] [Related]
6. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
7. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH
Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472
[TBL] [Abstract][Full Text] [Related]
8. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.
Chiappetta G; Fabien N; Picone A; Califano D; Monaco C; de Franciscis V; Vecchio G; Santelli G
Oncol Res; 1996; 8(2):85-93. PubMed ID: 8859779
[TBL] [Abstract][Full Text] [Related]
10. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
12. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG
Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
14. Modeling and preclinical trials for gliomas.
Salpietro M; Holland EC
Clin Neurosurg; 2005; 52():104-11. PubMed ID: 16626060
[No Abstract] [Full Text] [Related]
15. Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.
Vanbrocklin MW; Robinson JP; Lastwika KJ; McKinney AJ; Gach HM; Holmen SL
Neuro Oncol; 2012 Jan; 14(1):34-42. PubMed ID: 22015595
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling enhances nestin expression in gliomas.
Shih AH; Holland EC
Neoplasia; 2006 Dec; 8(12):1072-82. PubMed ID: 17217625
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
[TBL] [Abstract][Full Text] [Related]
20. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
